Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Zupi, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Supino, R; Perego, P; Gatti, L; Caserini, C; Leonetti, C; Colantuono, M; Zuco, V; Carenini, N; Zupi, G; Zunino, F
      A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line

      EUROPEAN JOURNAL OF CANCER
    2. Leonetti, C; Biroccio, A; Benassi, B; Stringaro, A; Stoppacciaro, A; Semple, SC; Zupi, G
      Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line

      CANCER GENE THERAPY
    3. Del Bufalo, D; Trisciuoglio, D; Biroccio, A; Marcocci, L; Buglioni, S; Candiloro, A; Scarsella, M; Leonetti, C; Zupi, G
      Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity

      JOURNAL OF CELLULAR BIOCHEMISTRY
    4. Biroccio, A; Benassi, B; Amodei, S; Gabellini, C; Del Bufalo, D; Zupi, G
      C-myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells

      MOLECULAR PHARMACOLOGY
    5. Biroccio, A; Benassi, B; D'Agnano, I; D'Angelo, C; Buglioni, S; Mottolese, M; Ricciotti, A; Citro, G; Cosimelli, M; Ramsay, RG; Calabretta, B; Zupi, G
      c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer - Clinical and experimental findings

      AMERICAN JOURNAL OF PATHOLOGY
    6. Buglioni, S; D'Agnano, I; Vasselli, S; Donnorso, RP; D'Angelo, C; Brenna, A; Benevelo, M; Cosimelli, M; Zupi, G; Mottolese, M
      p53 nuclear accumulation and multiploidy are adverse prognostic factors insurgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy

      AJCP. American journal of clinical pathology
    7. Biroccio, A; Candiloro, A; Mottolese, M; Sapora, O; Albini, A; Zupi, G; Del Bufalo, D
      Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line

      FASEB JOURNAL
    8. Turco, A; Scarpa, S; Coppa, A; Baccheschi, G; Palumbo, C; Leonetti, C; Zupi, G; Colletta, G
      Increased TGF beta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells

      EXPERIMENTAL CELL RESEARCH
    9. Putney, SD; Brown, J; Cucco, C; Lee, R; Skorski, T; Leonetti, C; Geiser, T; Calabretta, B; Zupi, G; Zon, G
      Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    10. Leonetti, C; Biroccio, A; Candiloro, A; Citro, G; Fornari, C; Mottolese, M; Del Bufalo, D; Zupi, G
      Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotidesin a human metastatic melanoma inherently resistant to cisplatin

      CLINICAL CANCER RESEARCH
    11. Biroccio, A; Del Bufalo, D; Ricca, A; D'Angelo, C; D'Orazi, G; Sacchi, A; Soddu, S; Zupi, G
      Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule

      GENE THERAPY
    12. TURCO A; COPPA A; ALOE S; BACCHESCHI G; MORRONE S; ZUPI G; COLLETTA G
      OVEREXPRESSION OF TRANSFORMING-GROWTH-FACTOR BETA-TYPE II RECEPTOR REDUCES TUMORIGENICITY AND METASTASTIC POTENTIAL OF K-RAS-TRANSFORMED THYROID-CELLS

      International journal of cancer
    13. Buglioni, S; D'Agnano, I; Cosimelli, M; Vasselli, S; D'Angelo, C; Tedesco, M; Zupi, G; Mottolese, M
      Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and Bcl-2

      INTERNATIONAL JOURNAL OF CANCER
    14. Biroccio, A; Del Bufalo, D; Fanciulli, M; Bruno, T; Zupi, G; Floridi, A
      bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells

      INTERNATIONAL JOURNAL OF CANCER
    15. DIFILIPPO F; ANZA M; ROSSI CR; CAVALIERE F; BOTTI C; LISE M; GARINEI R; GIANNARELLI D; VASSELLI S; ZUPI G; CAVALIERE R
      THE APPLICATION OF HYPERTHERMIA IN REGIONAL CHEMOTHERAPY

      Seminars in surgical oncology
    16. DAGNANO I; ANTONELLI A; BUCCI B; MARCUCCI L; PETRINELLI P; AMBRA R; ZUPI G; ELLI R
      EFFECTS OF POLY(ADP-RIBOSE) POLYMERASE INHIBITION ON CELL-DEATH AND CHROMOSOME-DAMAGE INDUCED BY VP16 AND BLEOMYCIN

      Environmental and molecular mutagenesis
    17. COSIMELLI M; DAGNANO I; TEDESCO M; DANGELO C; BOTTI C; GIANNARELLI D; VASSELLI S; CAVALIERE F; ZUPI G; CAVALIERE R
      THE ROLE OF MULTIPLOIDY AS UNFAVORABLE PROGNOSTIC VARIABLE IN COLORECTAL-CANCER

      Anticancer research
    18. CITRO G; DAGNANO I; LEONETTI C; PERINI R; BUCCI B; ZON G; CALABRETTA B; ZUPI G
      C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDES ENHANCE THE EFFICACY OF CISPLATIN IN MELANOMA CHEMOTHERAPY IN-VITRO AND IN NUDE-MICE

      Cancer research
    19. DALBUFALO D; LEONETTI C; BUCCI B; AMEDEO C; FALCIONI R; BIROCCIO A; ZUPI G
      N-METHYLFORMAMIDE INDUCES CHANGES ON ADHESIVE PROPERTIES AND LUNG-COLONIZING POTENTIAL OF M14 MELANOMA-CELLS

      British Journal of Cancer
    20. DELBUFALO D; BIROCCIO A; LEONETTI C; ZUPI G
      BCL-2 OVEREXPRESSION ENHANCES THE METASTATIC POTENTIAL OF A HUMAN BREAST-CANCER LINE

      The FASEB journal
    21. BUCCI B; DAGNANO I; BOTTI C; MOTTOLESE M; CARICO E; ZUPI G; VECCHIONE A
      EGF-R EXPRESSION IN DUCTAL BREAST-CANCER - PROLIFERATION AND PROGNOSTIC IMPLICATIONS

      Anticancer research
    22. SANTORO E; CARBONI M; CATARCI M; CARLINI M; CARBONI F; ZUPI G; VECCHIONE A; DAGNANO I; GIANNARELLI D; SANTORO R; GAROFALO A
      DNA-PLOIDY, PROLIFERATIVE INDEX AND EGF-R STATUS IN 130 CASES OF RESECTED GASTRIC-CANCER - A MULTIVARIATE-ANALYSIS

      Hepato-gastroenterology
    23. GERVASI F; DAGNANO I; VOSSIO S; ZUPI G; SACCHI A; LOMBARDI D
      NM23 INFLUENCES PROLIFERATION AND DIFFERENTIATION OF PC12 CELLS IN RESPONSE TO NERVE GROWTH-FACTOR

      Cell growth & differentiation
    24. FANCIULLI M; VALENTINI A; BRUNO T; CITRO G; ZUPI G; FLORIDI A
      EFFECT OF THE ANTITUMOR DRUG LONIDAMINE ON GLUCOSE-METABOLISM OF ADRIAMYCIN-SENSITIVE AND ADRIAMYCIN-RESISTANT HUMAN BREAST-CANCER CELLS

      Oncology research
    25. DELBUFALO D; BIROCCIO A; SODDU S; LAUDONIO N; DANGELO C; SACCHI A; ZUPI G
      LONIDAMINE INDUCES APOPTOSIS IN DRUG-RESISTANT CELLS INDEPENDENTLY OFTHE P53 GENE

      The Journal of clinical investigation
    26. DIPAOLO MC; RICCI F; CONSTANTINI RM; CAMA A; PALMIROTTA R; CURIA MC; MARCHEGGIANO A; ZUPI G; DAGNANO I; PAOLUZI OA; ROSSI P; BATTISTA P; VERI MC; IANNONE C; PAOLUZI P
      CANCER-RISK SURVEILLANCE IN LONG-STANDING ULCERATIVE-COLITIS PATIENTS- PRELIMINARY-REPORT

      Gastroenterology
    27. DELBUFALO D; CUCCO C; LEONETTI C; CITRO G; DAGNANO I; BENASSI M; GEISER T; ZON G; CALABRETTA B; ZUPI G
      EFFECT OF CISPLATIN AND C-MYB ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES COMBINATION ON A HUMAN COLON-CARCINOMA CELL-LINE IN-VITRO AND IN-VIVO

      British Journal of Cancer
    28. LEONETTI C; DAGNANO I; LOZUPONE F; VALENTINI A; GEISER T; ZON G; CALABRETTA B; CITRO G; ZUPI G
      ANTITUMOR EFFECT OF C-MYC ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES ON HUMAN-MELANOMA CELLS IN-VITRO AND IN MICE

      Journal of the National Cancer Institute
    29. SPALLETTICERNIA D; DAGNANO I; SALVATORE C; PORTELLA G; ZUPI G; VECCHIO G; LACCETTI P
      TRANSFORMATION BY V-RAS ONCOGENE CORRELATES WITH AN INCREASED DRUG-RESISTANCE IN AN EPITHELIAL THYROID-CELL SYSTEM

      International journal of oncology
    30. BUCCI B; PANSADORO V; DEPAULA F; FLORIO A; CARICO E; ZUPI G; VECCHIONE A
      BIOLOGIC CHARACTERISTICS OF T1 PAPILLARY BLADDER-CANCER - FLOW CYTOMETRIC STUDY OF PARAFFIN-EMBEDDED MATERIAL

      Analytical and quantitative cytology and histology
    31. POPERT RJM; MASTERS JRW; COPTCOAT M; ZUPI G
      RELATIVE CYTOTOXICITIES OF ADRIAMYCIN AND EPIRUBICIN IN COMBINATION WITH LONIDAMINE AGAINST HUMAN BLADDER-CANCER CELL-LINES

      Urological research
    32. ZUPI G; MOLINARI A; DAGNANO I; MESCHINI S; DELBUFALO D; MATARRESE P; CANDILORO A; CALCABRINI A; CITRO G; ARANCIA G
      ADRIAMYCIN RESISTANCE MODULATION INDUCED BY LONIDAMINE IN HUMAN BREAST-CANCER CELLS

      Anticancer research
    33. DAGNANO I; DANGELO C; SAVARESE A; CARLINI M; GAROFALO A; BOTTARI L; SANTORO E; GIANNARELLI D; VECCHIONE A; ZUPI G
      DNA-PLOIDY, PROLIFERATIVE INDEX, AND EPIDERMAL GROWTH-FACTOR RECEPTOR- EXPRESSION AND PROGNOSIS IN PATIENTS WITH GASTRIC CANCERS

      Laboratory investigation
    34. DELBUFALO D; ZUPI G
      IN-VITRO POTENTIATION OF EPIRUBICIN ACTIVITY BY LONIDAMINE IN A HUMANBREAST-CANCER CELL-LINE

      International journal of oncology
    35. FERRARI S; MANFREDINI R; TAGLIAFICO E; GRANDE A; BARBIERI D; BALESTRI R; PIZZANELLI M; ZUCCHINI P; CITRO G; ZUPI G; FRANCESCHI C; TORELLI U
      ANTIAPOPTOTIC EFFECT OF C-FES PROTOONCOGENE DURING GRANULOCYTIC DIFFERENTIATION

      Leukemia
    36. ARANCIA G; MESCHINI S; MATARRESE P; MALORNI W; CANDILORO A; MATTIONI M; SANTONI G; ZUPI G
      MODULATION OF THE EFFECTS OF THE HYPERTHERMIC TREATMENT BY N-METHYLFORMAMIDE ON A HUMAN-MELANOMA CELL-LINE

      Anticancer research
    37. SILVESTRINI R; LUISI A; DAIDONE MG; COSTA A; VALENTINIS B; ZUPI G; DAGNANO I; GEIDO E; GIARETTI W; PEPE S; RUGGIERO A; RUSSO A; BAZAN V; FACCHINI A; LALLI E; MAZZINI G; UNGARI S; RIBA S
      QUALITY-CONTROL FOR EVALUATION OF THE S-PHASE FRACTION BY FLOW-CYTOMETRY - A MULTICENTRIC STUDY

      Cytometry
    38. CARLINI M; GAROFALO A; RINALDI G; DAGNANO I; DANGELO C; ZUPI G; VECCHIONE A; SANTORO E
      GASTRIC-CANCER CELL-DNA CONTENT CORRELATES WITH EARLY AND LATE RESULTS AFTER GASTRECTOMY

      International surgery
    39. FALCIONI R; CIMINO L; GENTILESCHI MP; DAGNANO I; ZUPI G; KENNEL SJ; SACCHI A
      EXPRESSION OF BETA-1, BETA-3, BETA-4, AND BETA-5 INTEGRINS BY HUMAN LUNG-CARCINOMA CELLS OF DIFFERENT HISTOTYPES

      Experimental cell research
    40. ARANCIA G; MOLINARI A; CALCABRINI A; CITRO G; VILLA AM; VERDINA A; ZUPI G
      EFFECTS OF SEQUENTIAL COMBINATIONS OF N-METHYLFORMAMIDE WITH ADRIAMYCIN ON CULTURED MELANOMA-CELLS (M14)

      Experimental and molecular pathology
    41. DELBUFALO D; BUCCI B; DAGNANO I; ZUPI G
      N-METHYLFORMAMIDE AS A POTENTIAL THERAPEUTIC APPROACH IN COLON-CANCER

      Diseases of the colon & rectum
    42. CITRO G; SZCZYLIK C; GINOBBI P; ZUPI G; CALABRETTA B
      INHIBITION OF LEUKEMIA-CELL PROLIFERATION BY FOLIC-ACID POLYLYSINE-MEDIATED INTRODUCTION OF C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES INTO HL-60 CELLS

      British Journal of Cancer
    43. SAVARESE A; CUCCO C; ZUPI G
      EFFECTIVENESS OF THE COMBINATION DDP - AR IN INDUCING CYTOTOXIC EFFECT ON A HUMAN GLIOBLASTOMA CELL-LINE

      Cytotechnology
    44. DAGNANO I; COSIMELLI M; LAPERA A; CAVALIERE F; MANNELLA E; GIANNARELLI D; CAVALIERE R; ZUPI G
      FLOW CYTOMETRIC ANALYSIS OF DNA CONTENT AND CELL-KINETICS IN COLORECTAL-CARCINOMA

      Anticancer research
    45. MANFREDINI R; GRANDE A; TAGLIAFICO E; BARBIERI D; ZUCCHINI P; CITRO G; ZUPI G; FRANCESCHI C; TORELLI U; FERRARI S
      INHIBITION OF C-FES EXPRESSION BY AN ANTISENSE OLIGOMER CAUSES APOPTOSIS OF HL-60 CELLS INDUCED TO GRANULOCYTIC DIFFERENTIATION

      The Journal of experimental medicine
    46. SILVESTRINI R; DAGNANO I; FARANDA A; COSTA A; ZUPI G; COSIMELLI M; QUAGLIUOLO V; GIANNARELLI D; GENNARI L; CAVALIERE R
      FLOW CYTOMETRIC ANALYSIS OF PLOIDY IN COLORECTAL-CANCER - A MULTICENTRIC EXPERIENCE

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 21:15:25